Merck (MRK)

• Market cap: $213B
• 1 day: 1.65%
• 5 days: 0.42%
• 1 month: -3.4%
• 3 months: 7.98%
• 6 months: 8.53%
• Year to date: -13.5%
• 1 year: -14.84%
• 5 years: 11.87%
• 10 years: 64.61%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Employees: 75,000